Maria P M Marques Selected Research

N(1)- ethyl- N- (11)- ((cyclopropyl)methyl)- 4,8- diazaundecane- 1,11- diamine

2/2014

Increased breast cancer cell toxicity by palladination of the polyamine analogue N (1),N (11)-bis(ethyl)norspermine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria P M Marques Research Topics

Disease

7	Breast Neoplasms (Breast Cancer) 01/2022 - 05/2011
5	Neoplasms (Cancer) 01/2022 - 02/2021
2	Triple Negative Breast Neoplasms 01/2022 - 01/2019
1	Weight Loss (Weight Reduction) 01/2022
1	Margins of Excision 10/2021
1	Osteosarcoma (Osteogenic Sarcoma) 08/2021
1	Burns 12/2020
1	Body Remains 12/2020

Drug/Important Bio-Agent (IBA)

5	PalladiumIBA 01/2022 - 06/2011
5	SpermineIBA 01/2022 - 06/2011
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2011
3	Pharmaceutical PreparationsIBA 01/2022 - 02/2014
2	MetalsIBA 08/2021 - 02/2014
2	Biological ProductsIBA 12/2020 - 06/2011
2	PolyaminesIBA 01/2016 - 02/2014
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Complement System Proteins (Complement)IBA 10/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2021
1	LigandsIBA 08/2021
1	PlatinumIBA 08/2021
1	Docetaxel (Taxotere)FDA Link 01/2016
1	N(1)- ethyl- N- (11)- ((cyclopropyl)methyl)- 4,8- diazaundecane- 1,11- diamineIBA 02/2014
1	N(1),N(11)-diethylnorspermineIBA 02/2014
1	Estrogens (Estrogen)FDA Link 05/2011
1	ferulic acid (sodium ferulate)IBA 05/2011

Therapy/Procedure

2	Therapeutics 02/2021 - 01/2019